KNBIF
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $43,329 | -$486,904 |
| 2025 Q4 | -0.00 | -$21,489 | -$582,743 |
| 2025 Q3 | -0.00 | $8,499 | -$703,828 |
| 2025 Q2 | -0.00 | $27,997 | -$822,564 |
| 2025 Q1 | -0.01 | $412,513 | -$1M |
| 2024 Q4 | -0.01 | $125,858 | -$461,106 |
| 2024 Q3 | -0.00 | $1M | -$546,584 |
| 2024 Q2 | 0.07 | $620,437 | -$2M |